Table 3.
Variables | All Sepsis (CPS + CNS) | p † | CPS | p § | CNS | p ¥ | Infants without Sepsis |
---|---|---|---|---|---|---|---|
n = 76 | n = 33 | n = 33 | n = 76 | ||||
Neurodevelopmental outcome | 0.008 | 0.004 | 0.063 | ||||
|
47 (61.8) | 18 (54.6) | 29 (67.5) | 59 (77.6) | |||
|
10 (13.2) | 5 (15.2) | 5 (11.6) | 12 (15.8) | |||
|
19 (25.0) | 10 (30.3) ‡ | 9 (20.9) ¶ | 5 (6.6) * | |||
Motor outcome | 0.003 | 0.007 | 0.137 | ||||
|
50 (65.8) | 18 (55.6) | 32 (74.4) | 62 (81.6) | |||
|
14 (18.4) | 9 (27.3) | 5 (11.6) | 11 (14.5) | |||
|
12 (15.8) | 6 (18.2) | 6 (14.0) | 3 (3.9) | |||
GMDS-R ‖ | |||||||
A | 98 (98–107) | 0.322 | 98 (98–107) | 0.387 | 98 (98–107) | 0.458 | 98 (98–107) |
B | 106 (99–115) | 0.038 | 106 (92–106) | 0.006 | 109 (99–119) | 0.416 | 112 (100–119) |
C | 101 (88–105) | 0.621 | 98 (84–102) | 0.179 | 102 (91–107) | 0.719 | 102 (88–105) |
D | 107(102–112) | 0.762 | 107 (102–112) | 0.259 | 107 (102–118) | 0.644 | 107 (102–118) |
E | 101 (99–106) | 0.286 | 100 (99–106) | 0.497 | 102 (100–106) | 0.319 | 106 (100–106) |
GQ | 103 (96–109) | 0.264 | 100 (95–106) | 0.033 | 105 (97–111) | 0.931 | 105 (98–111) |
A—loco-motor scale. B—eye and hand coordination scale. C—personal and social scale. CNS—culture-negative sepsis. CPS—culture-proven sepsis. D—hearing and language scale. E—cognitive performance scale. GMDS-R—Griffiths Mental Development Scale. GQ—general development quotient. MFD—moderate functional disability. SFD—severe functional disability. Data presented as median (interquartile range) or n (%). † Comparison between infants with sepsis and infants without sepsis. § Comparison between infants with CPS and infants without sepsis. ¥ Comparison between infants with CNS and infants without sepsis. ‡ SFD: cerebral palsy, n = 6 (of whom one also had deafness). Blindness, n = 4. ¶ SFD: cerebral palsy, n = 7 (of whom one also had blindness). Severe cognitive impairment, n = 2. * SFD: cerebral palsy, n = 3. Blindness, n = 1. Severe cognitive impairment, n = 1. ‖ A total of 21 infants with cerebral palsy (n = 16) or blindness (n = 6) were excluded from the analysis. In addition, data were unavailable for 3 infants. Number of infants included in the final analysis were distributed as follows: infants with all sepsis (CPS + CNS), n = 56; infants with CPS, n = 23; infants with CNS, n = 33; infants without sepsis, n = 73.